Human aldo-keto reductases: Function, gene regulation, and single nucleotide polymorphisms.

Aldo-keto reductases (AKRs) are a superfamily of NAD(P)H linked oxidoreductases that are generally monomeric 34-37kDa proteins present in all phyla. The superfamily consists of 15 families, which contains 151 members (www.med.upenn.edu/akr). Thirteen human AKRs exist that use endogenous substrates (sugar and lipid aldehydes, prostaglandins, retinals and steroid hormones), and in many instances they regulate nuclear receptor signaling. Exogenous substrates include metabolites implicated in chemical carcinogenesis: NNK (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone), polycyclic aromatic hydrocarbon trans-dihydrodiols, and aflatoxin dialdehyde. Promoter analysis of the human genes identifies common elements involved in their regulation which include osmotic response elements, anti-oxidant response elements, xenobiotic response elements, AP-1 sites and steroid response elements. The human AKRs are highly polymorphic, and in some instances single nucleotide polymorphisms (SNPs) of high penetrance exist. This suggests that there will be inter-individual variation in endogenous and xenobiotic metabolism which in turn affect susceptibility to nuclear receptor signaling and chemical carcinogenesis.

[1]  T. Penning,et al.  Human cytosolic 3alpha-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3beta-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action. , 2003, The Journal of biological chemistry.

[2]  S. Wrighton,et al.  The human hepatic cytochromes P450 involved in drug metabolism. , 1992, Critical reviews in toxicology.

[3]  P. Scambler,et al.  Mutations in SRD5B1 (AKR1D1), the gene encoding delta(4)-3-oxosteroid 5beta-reductase, in hepatitis and liver failure in infancy. , 2003, Gut.

[4]  S. Hecht,et al.  Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers and metabolites in the A/J mouse. , 1999, Carcinogenesis.

[5]  T. Rushmore,et al.  The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. , 1991, The Journal of biological chemistry.

[6]  J. Bolton,et al.  Role of quinoids in estrogen carcinogenesis. , 1998, Chemical research in toxicology.

[7]  T. Terada,et al.  Characterization of a novel variant (S145C/L311V) of 3alpha-hydroxysteroid/dihydrodiol dehydrogenase in human liver. , 1999, Pharmacogenetics.

[8]  A. Troxel,et al.  Formation of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dGuo) by PAH o-quinones: involvement of reactive oxygen species and copper(II)/copper(I) redox cycling. , 2005, Chemical research in toxicology.

[9]  J. Shoda,et al.  Gene analysis in δ 4 -3-oxosteroid 5β–reductase deficiency , 1997, The Lancet.

[10]  A. Pegg,et al.  The repair of the tobacco specific nitrosamine derived adduct O6-[4-Oxo-4-(3-pyridyl)butyl]guanine by O6-alkylguanine-DNA alkyltransferase variants. , 2004, Chemical research in toxicology.

[11]  T. Penning,et al.  Generation of reactive oxygen species during the enzymatic oxidation of polycyclic aromatic hydrocarbon trans-dihydrodiols catalyzed by dihydrodiol dehydrogenase. , 1996, Chemical research in toxicology.

[12]  E. Jacquemin,et al.  SRD5B1 (AKR1D1) gene analysis in Δ4-3-oxosteroid 5β-reductase deficiency: evidence for primary genetic defect , 2004 .

[13]  E. Maser,et al.  Enantioselectivity of carbonyl reduction of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone by tissue fractions from human and rat and by enzymes isolated from human liver. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[14]  R. Cole,et al.  Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Field,et al.  Reactive oxygen species generated by PAH o-quinones cause change-in-function mutations in p53. , 2002, Chemical research in toxicology.

[16]  D. Peehl,et al.  Expression and Characterization of Recombinant Type 2 3α-Hydroxysteroid Dehydrogenase (HSD) from Human Prostate: Demonstration of Bifunctional 3α/17β-HSD Activity and Cellular Distribution , 1997 .

[17]  L. Marnett,et al.  Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons. , 1989, Cancer research.

[18]  J. Jez,et al.  Mutagenesis of 3 alpha-hydroxysteroid dehydrogenase reveals a "push-pull" mechanism for proton transfer in aldo-keto reductases. , 1998, Biochemistry.

[19]  M. J. Bennett,et al.  Structure and function of 3α-hydroxysteroid dehydrogenase , 1997, Steroids.

[20]  D. Harrison,et al.  Molecular cloning, expression and catalytic activity of a human AKR7 member of the aldo-keto reductase superfamily: evidence that the major 2-carboxybenzaldehyde reductase from human liver is a homologue of rat aflatoxin B1-aldehyde reductase. , 1998, The Biochemical journal.

[21]  I. Björkhem,et al.  Cloning and expression of cDNA of human Δ4‐3‐oxosteroid 5β‐reductase and substrate specificity of the expressed enzyme , 1994 .

[22]  F. Carrilho,et al.  A prospective study of the prevalence of hepatitis B and C virus co-infection among patients with chronic renal disease under hemodialysis. , 2004, Journal of hepatology.

[23]  J. Hayes,et al.  Novel homodimeric and heterodimeric rat gamma-hydroxybutyrate synthases that associate with the Golgi apparatus define a distinct subclass of aldo-keto reductase 7 family proteins. , 2002, The Biochemical journal.

[24]  R Ohlsson,et al.  Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  T. Penning,et al.  Reactivity of benzo[a]pyrene-7,8-dione with DNA. Evidence for the formation of deoxyguanosine adducts. , 1993, Carcinogenesis.

[26]  S. Ito,et al.  Synthesis of prostaglandin F ethanolamide by prostaglandin F synthase and identification of Bimatoprost as a potent inhibitor of the enzyme: new enzyme assay method using LC/ESI/MS. , 2004, Archives of biochemistry and biophysics.

[27]  T. Flynn,et al.  Sequence and expression levels in human tissues of a new member of the aldo-keto reductase family. , 1998, Biochimica et biophysica acta.

[28]  S. Srivastava,et al.  Identification of biochemical pathways for the metabolism of oxidized low-density lipoprotein derived aldehyde-4-hydroxy trans-2-nonenal in vascular smooth muscle cells. , 2001, Atherosclerosis.

[29]  T. Curran,et al.  The redox and DNA-repair activities of Ref-1 are encoded by nonoverlapping domains. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[30]  N. Palackal,et al.  Dihydrodiol dehydrogenases and polycyclic aromatic hydrocarbon activation: generation of reactive and redox active o-quinones. , 1999, Chemical research in toxicology.

[31]  Michael E. Burczynski,et al.  Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1–AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones , 2000 .

[32]  A. Hara,et al.  Identification of amino acid residues responsible for differences in substrate specificity and inhibitor sensitivity between two human liver dihydrodiol dehydrogenase isoenzymes by site-directed mutagenesis. , 1997, The Biochemical journal.

[33]  S. Hecht,et al.  Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. , 1998, Chemical research in toxicology.

[34]  J. Groopman,et al.  cDNA cloning, expression and activity of a second human aflatoxin B1-metabolizing member of the aldo-keto reductase superfamily, AKR7A3. , 1999, Carcinogenesis.

[35]  T. Penning,et al.  The kinetic mechanism catalysed by homogeneous rat liver 3 alpha-hydroxysteroid dehydrogenase. Evidence for binary and ternary dead-end complexes containing non-steroidal anti-inflammatory drugs. , 1991, The Biochemical journal.

[36]  Hiroyuki Aburatani,et al.  Overexpression of the Aldo-Keto Reductase Family Protein AKR1B10 Is Highly Correlated with Smokers' Non–Small Cell Lung Carcinomas , 2005, Clinical Cancer Research.

[37]  Yue Xiong,et al.  BTB Protein Keap1 Targets Antioxidant Transcription Factor Nrf2 for Ubiquitination by the Cullin 3-Roc1 Ligase , 2005, Molecular and Cellular Biology.

[38]  I. Blair,et al.  Synthesis and characterization of polycyclic aromatic hydrocarbon o-quinone depurinating N7-guanine adducts. , 1999, Chemical research in toxicology.

[39]  M. Nishizawa,et al.  cDNA cloning, expression and characterization of human prostaglandin F synthase 1 , 1999 .

[40]  A. Hartmann,et al.  (www.interscience.wiley.com) DOI: 10.1002/path.2039 , 2006 .

[41]  K. Žarković.  4-hydroxynonenal and neurodegenerative diseases. , 2003, Molecular aspects of medicine.

[42]  M. Lazar,et al.  Prostaglandins Promote and Block Adipogenesis through Opposing Effects on Peroxisome Proliferator-activated Receptor γ* , 1998, The Journal of Biological Chemistry.

[43]  James E. Bray,et al.  Enzymology and Molecular Biology of Carbonyl Metabolism , 2005 .

[44]  W. Wasserman,et al.  Functional antioxidant responsive elements. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[45]  S. Wehrli,et al.  Covalent modifications to 2'-deoxyguanosine by 4-oxo-2-nonenal, a novel product of lipid peroxidation. , 1999, Chemical research in toxicology.

[46]  I. Blair,et al.  Competing roles of aldo-keto reductase 1A1 and cytochrome P4501B1 in benzo[a]pyrene-7,8-diol activation in human bronchoalveolar H358 cells: role of AKRs in P4501B1 induction. , 2006, Chemical research in toxicology.

[47]  D. Peehl,et al.  Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells. , 2003, Endocrinology.

[48]  P. Talalay,et al.  Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver. , 1988, Cancer research.

[49]  C. Lai,et al.  Human aldose reductase: rate constants for a mechanism including interconversion of ternary complexes by recombinant wild-type enzyme. , 1995, Biochemistry.

[50]  S. Hecht,et al.  Quantitation of pyridyloxobutyl DNA adducts of tobacco-specific nitrosamines in rat tissue DNA by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry. , 2006, Chemical research in toxicology.

[51]  B. Wermuth,et al.  Primary structure of aldehyde reductase from human liver. , 1987, Progress in clinical and biological research.

[52]  M. Reilly,et al.  Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma. , 2003, The Journal of clinical investigation.

[53]  S. Chung,et al.  Identification and Characterization of Multiple Osmotic Response Sequences in the Human Aldose Reductase Gene* , 1997, The Journal of Biological Chemistry.

[54]  M. Lewis,et al.  Three-dimensional structure of rat liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase: a member of the aldo-keto reductase superfamily. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Sheung Tat Fan,et al.  Identification and Characterization of a Novel Human Aldose Reductase-like Gene* , 1998, The Journal of Biological Chemistry.

[56]  O. Nosjean,et al.  Covalent binding of 15-deoxy-delta12,14-prostaglandin J2 to PPARgamma. , 2005, Biochemical and biophysical research communications.

[57]  B. Wermuth,et al.  The aldo-keto reductase superfamily. cDNAs and deduced amino acid sequences of human aldehyde and aldose reductases. , 1989, The Journal of biological chemistry.

[58]  N. Hattori,et al.  Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[59]  C. Chi,et al.  Hydroxychavicol modulates benzo[a]pyrene-induced genotoxicity through induction of dihydrodiol dehydrogenase. , 2004, Toxicology letters.

[60]  F. Guengerich,et al.  Kinetics of hydrolysis and reaction of aflatoxin B1 exo-8,9-epoxide and relevance to toxicity and detoxication. , 1999, Drug metabolism reviews.

[61]  N. Palackal,et al.  The Reactive Oxygen Species- and Michael Acceptor-inducible Human Aldo-Keto Reductase AKR1C1 Reduces the α,β-Unsaturated Aldehyde 4-Hydroxy-2-nonenal to 1,4-Dihydroxy-2-nonene* , 2000, The Journal of Biological Chemistry.

[62]  Nathaniel Rothman,et al.  Oxidative damage-related genes AKR1C3 and OGG1 modulate risks for lung cancer due to exposure to PAH-rich coal combustion emissions. , 2004, Carcinogenesis.

[63]  Seon-Hwa Lee,et al.  Characterization of 2'-deoxyadenosine adducts derived from 4-oxo-2-nonenal, a novel product of lipid peroxidation. , 2000, Chemical research in toxicology.

[64]  Donna M. Peehl,et al.  Aldo-keto reductase (AKR) 1C3: Role in prostate disease and the development of specific inhibitors , 2006, Molecular and Cellular Endocrinology.

[65]  A. Conney,et al.  Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. , 1982, Cancer research.

[66]  M. Lewis,et al.  Comparative anatomy of the aldo-keto reductase superfamily. , 1997, The Biochemical journal.

[67]  T. Penning,et al.  Expression and characterization of four recombinant human dihydrodiol dehydrogenase isoforms: oxidation of trans-7, 8-dihydroxy-7,8-dihydrobenzo[a]pyrene to the activated o-quinone metabolite benzo[a]pyrene-7,8-dione. , 1998, Biochemistry.

[68]  S. Nesnow,et al.  Identification and characterization of novel stable deoxyguanosine and deoxyadenosine adducts of benzo[a]pyrene-7,8-quinone from reactions at physiological pH. , 2004, Chemical research in toxicology.

[69]  A. Rao,et al.  NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[70]  Tea Lanišnik Rižner,et al.  AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer , 2006, Molecular and Cellular Endocrinology.

[71]  T. Montine,et al.  Elevation of AKR7A2 (succinic semialdehyde reductase) in neurodegenerative disease , 2001, Brain Research.

[72]  T. Penning,et al.  Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase. , 1999, Cancer research.

[73]  Akira,et al.  Identification of a principal mRNA species for human 3alpha-hydroxysteroid dehydrogenase isoform (AKR1C3) that exhibits high prostaglandin D2 11-ketoreductase activity. , 1998, Journal of biochemistry.

[74]  N. Palackal,et al.  Activation of Polycyclic Aromatic Hydrocarbontrans-Dihydrodiol Proximate Carcinogens by Human Aldo-keto Reductase (AKR1C) Enzymes and Their Functional Overexpression in Human Lung Carcinoma (A549) Cells* , 2002, The Journal of Biological Chemistry.

[75]  M. J. Bennett,et al.  Structure of 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase complexed with NADP+. , 1996, Biochemistry.

[76]  Masayuki Yamamoto,et al.  Oxidative Stress Sensor Keap1 Functions as an Adaptor for Cul3-Based E3 Ligase To Regulate Proteasomal Degradation of Nrf2 , 2004, Molecular and Cellular Biology.

[77]  K. Itoh,et al.  Dimerization of Substrate Adaptors Can Facilitate Cullin-mediated Ubiquitylation of Proteins by a “Tethering” Mechanism , 2006, Journal of Biological Chemistry.

[78]  A. Troxel,et al.  Polycyclic aromatic hydrocarbon (PAH) o-quinones produced by the aldo-keto-reductases (AKRs) generate abasic sites, oxidized pyrimidines, and 8-oxo-dGuo via reactive oxygen species. , 2006, Chemical research in toxicology.

[79]  K. Itoh,et al.  Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence. , 2003, The Biochemical journal.

[80]  L. Moore,et al.  Orphan Nuclear Receptors Constitutive Androstane Receptor and Pregnane X Receptor Share Xenobiotic and Steroid Ligands* , 2000, The Journal of Biological Chemistry.

[81]  S. K. Woo,et al.  Tonicity-responsive enhancer binding protein, a rel-like protein that stimulates transcription in response to hypertonicity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[82]  T. Curran,et al.  Redox activation of Fos‐Jun DNA binding activity is mediated by a DNA repair enzyme. , 1992, The EMBO journal.

[83]  Nadarajah Vigneswaran,et al.  Cigarette smoke condensate induces cytochromes P450 and aldo-keto reductases in oral cancer cells. , 2006, Toxicology letters.

[84]  T. Flynn,et al.  Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism. , 2003, The Biochemical journal.

[85]  Tzei-Yi Lin,et al.  Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer. , 2001, Cancer research.

[86]  H. Yamazaki,et al.  Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[87]  Jong Y. Park,et al.  The human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) DNA repair enzyme and its association with lung cancer risk. , 2004, Pharmacogenetics.

[88]  Seon-Hwa Lee,et al.  Vitamin C-Induced Decomposition of Lipid Hydroperoxides to Endogenous Genotoxins , 2001, Science.

[89]  R. Roeder,et al.  Fos and jun cooperate in transcriptional regulation via heterologous activation domains , 1990, Molecular and cellular biology.

[90]  M. Lazar,et al.  Transcriptional Activation by Peroxisome Proliferator-activated Receptor γ Is Inhibited by Phosphorylation at a Consensus Mitogen-activated Protein Kinase Site* , 1997, The Journal of Biological Chemistry.

[91]  H. Lou,et al.  Induction of AKR1C2 by Phase II Inducers: Identification of a Distal Consensus Antioxidant Response Element Regulated by NRF2 , 2006, Molecular Pharmacology.

[92]  T. Penning,et al.  Structure–function of human 3α-hydroxysteroid dehydrogenases: genes and proteins , 2004, Molecular and Cellular Endocrinology.

[93]  S. Nesnow,et al.  Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts. , 2006, Analytical biochemistry.

[94]  T. Flynn,et al.  A new nomenclature for the aldo-keto reductase superfamily. , 1997, Biochemical pharmacology.

[95]  T. Penning,et al.  Genotoxic polycyclic aromatic hydrocarbon ortho-quinones generated by aldo-keto reductases induce CYP1A1 via nuclear translocation of the aryl hydrocarbon receptor. , 2000, Cancer research.

[96]  B. Rudy,et al.  Alternative splicing of the human Shaker K+ channel β1 gene and functional expression of the β2 gene product , 1995 .

[97]  Kevin M Williams,et al.  Reaction of aflatoxin B(1) oxidation products with lysine. , 2002, Chemical research in toxicology.

[98]  T. Penning,et al.  Dissection of the Physiological Interconversion of 5α-DHT and 3α-Diol by Rat 3α-HSD via Transient Kinetics Shows That the Chemical Step Is Rate-Determining: Effect of Mutating Cofactor and Substrate-Binding Pocket Residues on Catalysis† , 2004 .

[99]  T. Rushmore,et al.  Transcriptional regulation of a rat liver glutathione S-transferase Ya subunit gene. Analysis of the antioxidant response element and its activation by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate. , 1994, The Journal of biological chemistry.

[100]  N. Palackal,et al.  The ubiquitous aldehyde reductase (AKR1A1) oxidizes proximate carcinogen trans-dihydrodiols to o-quinones: potential role in polycyclic aromatic hydrocarbon activation. , 2001, Biochemistry.

[101]  T. Curran,et al.  Redox regulation of fos and jun DNA-binding activity in vitro. , 1990, Science.

[102]  J. Jez,et al.  The aldo-keto reductase (AKR) superfamily: an update. , 2001, Chemico-biological interactions.

[103]  T. Penning,et al.  Multiple steps determine the overall rate of the reduction of 5alpha-dihydrotestosterone catalyzed by human type 3 3alpha-hydroxysteroid dehydrogenase: implications for the elimination of androgens. , 2006, Biochemistry.

[104]  M. Suzuki,et al.  Diagnosis of the first Japanese patient with 3-oxo-Δ4-steroid 5β-reductase deficiency by use of immunoblot analysis , 1998, European Journal of Pediatrics.

[105]  G. Balendiran,et al.  Selective recognition of glutathiolated aldehydes by aldose reductase. , 2000, Biochemistry.

[106]  G. Petsko,et al.  Tyrosine-48 is the proton donor and histidine-110 directs substrate stereochemical selectivity in the reduction reaction of human aldose reductase: enzyme kinetics and crystal structure of the Y48H mutant enzyme. , 1994, Biochemistry.

[107]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.

[108]  M. J. Bennett,et al.  Steroid recognition and regulation of hormone action: crystal structure of testosterone and NADP+ bound to 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase. , 1997, Structure.

[109]  D. Moore,et al.  Nuclear Receptor-Dependent Bile Acid Signaling Is Required for Normal Liver Regeneration , 2006, Science.

[110]  A. Rao,et al.  Bridging the NFAT and NF-κB Families , 2001 .

[111]  R. Hayden,et al.  The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs. , 2003, Cancer research.

[112]  H. Yamazaki,et al.  Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. , 1996, Cancer research.

[113]  T. Kensler,et al.  The role of Keap1 in cellular protective responses. , 2005, Chemical research in toxicology.